title: FDA notifications.  Complera approved.
mesh_terms: D000225:Adenine / Q000008:administration & dosage / Q000031:analogs & derivatives; D003841:Deoxycytidine / Q000008:administration & dosage / Q000031:analogs & derivatives; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004338:Drug Combinations; D004348:Drug Labeling; D000068679:Emtricitabine; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D009570:Nitriles / Q000008:administration & dosage; D063065:Organophosphonates / Q000008:administration & dosage; D011743:Pyrimidines / Q000008:administration & dosage; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D000068696:Rilpivirine; D000068698:Tenofovir; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D004338:Drug Combinations; D009570:Nitriles; D063065:Organophosphonates; D011743:Pyrimidines; D018894:Reverse Transcriptase Inhibitors; D003841:Deoxycytidine; D000068698:Tenofovir; D000068696:Rilpivirine; D000068679:Emtricitabine; D000225:Adenine